Clinical Trial Update: Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690 [Phase 2]

View source ↗

Summary

A Phase 2a study evaluating TK112690 for suppression of radiotherapy-induced mucositis is in early-phase status with unknown completion details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucositis

Drugs mentioned

• TK112690

Snippet

Sponsor: Tosk, Inc. | Conditions: Mucositis | Phase 2 | Status: UNKNOWN